Cathie Wood, head of Ark Investment Management, is known for making bold bets — but she’s not afraid to change course when ...

WASHINGTON (AP) — President Donald Trump is taking additional action to upset the world trade system, with plans to sign an ...

Stifel analysts maintained their Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA), currently trading at $5.24, with a steady price target of $21.00. According to InvestingPro data, analyst targets ...

The bank's clients are likely involved in the basis trade, rather than making a directional bet, said an analyst.

Goldman Sachs (GS) is making more than a cautious entry into crypto—they’re jumping in with both feet. The powerhouse ...

Goldman Sachs kept buying spot Bitcoin and Ether ETFs in the fourth quarter of 2024 — increasing positions by 114% and 2,000% ...

Goldman Sachs (GS) is ending the pledge it made to refuse IPO business with companies that had all White, male boards, Bloomberg’s Sridhar ...

Goldman Sachs cancelled a four-year-old policy to only take public companies that had two diverse board members, a ...

Goldman Sachs will drop a demand that corporate boards of directors include women and members of minority groups as financial ...